Chemcon Speciality Chemicals Limited

Chemcon Speciality Chemicals Limited, incorporated in 1988, is an Indian manufacturer of specialized chemicals including pharmaceutical intermediates, oilfield chemicals, and silanes. The company specializes in the production of high-purity chemicals such as Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), which are critical inputs in the synthesis of active pharmaceutical ingredients (APIs). Headquartered in Vadodara, Gujarat, the company operates manufacturing facilities equipped with modern reaction capabilities and quality testing infrastructure. Chemcon serves a diverse clientele across domestic and international markets, supplying major pharmaceutical companies such as Hetero Labs, Laurus Labs, Aurobindo Pharma, and Macleods Pharmaceuticals. The company exports its products to multiple countries including the United States, China, Japan, Russia, and Spain. With a focus on specialized niche chemicals, Chemcon holds leading market shares in specific product segments within India. The company continues to expand its manufacturing capacity and product offerings to cater to growing demand in the pharmaceutical, oilfield, and agrochemical sectors, supported by certified quality management systems and environmental compliance standards.

Ahead of its public offering, Chemcon Speciality Chemicals raised Rs 95.40 crore from 13 anchor investors by allocating 2,805,880 equity shares at Rs 340 per share. Key anchor participants included ICICI Prudential Mutual Fund, IDFC Mutual Fund, Mirae Asset Mutual Fund, IIFL Special Opportunities Fund, and HSBC Global.